Vesilife 5mg Tablet
Marketer
MSN Laboratories
Salt Composition
Solifenacin (5mg)
Overview Vesilife 5mg Tablet
Overactive bladder is treated with Vesilife 5mg tablets, a muscarinic receptor blocker. This medication alleviates urinary issues such as frequent urination, urgency, and incontinence. Always follow your doctor's prescribed dosage and regimen for Vesilife 5mg. It can be administered with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Consult your physician before stopping the medication. Dry mouth, constipation, nausea, and urinary tract infections are potential side effects. Increased water intake may help mitigate these. Drowsiness or blurred vision can occur; avoid driving if affected. Prior to treatment, disclose all other medications and pre-existing conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require close monitoring and should follow their doctor's recommendations for regular check-ups.
Uses of Vesilife 5mg Tablet
Managing symptoms associated with overactive bladder
Major Benefits of Vesilife 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vesilife 5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Vesilife 5mg Tablet:
- Dryness in mouth
- Constipation
- Blurred vision
- Nausea
- Upset stomach
- Urinary tract infection
How to use Vesilife 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 5mg Vesilife tablet should be swallowed whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Vesilife 5mg Tablet works:
Urinary incontinence can be managed with Vesilife 5mg tablets, an antimuscarinic agent. This medication's action involves relaxing bladder muscles, thereby reducing episodes of frequent, urgent, or involuntary urination.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Vesilife 5mg tablets. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Vesilife 5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The 5mg Vesilife tablet appears safe for breastfeeding mothers. Available evidence indicates minimal risk to the infant. However, prolonged use of the 5mg Vesilife tablet may decrease breast milk supply and potentially lead to constipation, dry mouth, and urinary tract infections in the baby.
DrivingUNSAFE
Driving ability may be impaired by Vesilife 5mg Tablet side effects, including blurred vision and drowsiness.
KidneyCAUTION
For individuals with severe kidney impairment, Vesilife 5mg Tablet requires careful administration. Dosage modification of Vesilife 5mg Tablet may be necessary; physician consultation is advised. Vesilife 5mg Tablet is contraindicated for patients receiving kidney dialysis.
LiverCAUTION
Patients with liver impairment should use Vesilife 5mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Vesilife 5mg Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Vesilife 5mg Tablet :
Should you forget a Vesilife 5mg Tablet dose, administer it promptly. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vesilife 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinuclidine-tetrahydroisoquinoline hybrid |
| Developing Habits | No. |
| Treatment Category | Urology |
| Actions | M3 Muscarinic Receptor Antagonist (Bladder-Specific) |






